A day after General Electric's surprise announcement of a biopharma sale to Danaher, Wall Street crowed about the embattled industrial conglomerate's $21.4 billion deal.
GE shares rose 3 percent in trading Tuesday as several analysts pointed to GE's deal as a positive for the stock.
UBS analyst Peter Lennox-King believes this new source of cash for GE, as well as the benefits, is a boon for the company.
इंडिया ताज़ा खबर, इंडिया मुख्य बातें
Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।
'Stocks look like dead money': Here's why any US-China trade deal might disappoint Wall StreetInvestors want so much from a US-China trade deal that any agreement will disappoint them, says FTSE Russell's director of global markets research.
और पढो »
Facebook is starting to pay for some of its missteps and Wall Street is getting nervousFacebook is spending a lot of money on talking to lawmakers about the rules that will govern its business.
और पढो »
Economic data, healthcare shares pressure Wall StreetU.S. stocks edged lower on Thursday after a recent run of gains, pressured by we...
और पढो »
Wall Street doubts Kraft Heinz after it writes down two of its best known brandsKraft Heinz wrote down $15.4 billion in value on its Kraft and Oscar Mayer Brands in the fourth quarter. Wall Street analysts are doubting whether the company's cost-cutting strategy can work in today's competitive landscape.
और पढो »
Markets Right Now: Stocks are opening higher on Wall Street
और पढो »
Wall Street climbs as trade hopes power tech sharesU.S. stocks rose on Friday, as technology shares were boosted by signs of progre...
और पढो »